<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04212481</url>
  </required_header>
  <id_info>
    <org_study_id>Uniport VATS ZYP1</org_study_id>
    <nct_id>NCT04212481</nct_id>
  </id_info>
  <brief_title>RCT of Uniport VATS for Lung Cancer</brief_title>
  <official_title>Randomized Controlled Trial of the Comparison of Uniport VATS and Non- Uniport VATS for Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Second Hospital of Shandong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Second Hospital of Shandong University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Video-assisted thoracoscopic surgery (VATS) has been widely used for non-small cell lung
      cancer (NSCLC) for nearly two decades. Usually, it was applied through three ports with at
      least one drainage after surgery, which often lead to acute chest pain. Therefore, fewer,
      smaller ports, and wider intercostal space for surgery has been required.

      Uniport VATS became a feasible option with the development of surgical techniques and
      instruments, with potentially less postoperative pain and shorter hospital stays. However,
      there may be some complications, or with a longer time of operation, even more difficult in
      lymph nodes resection during learning curve.

      In our study, a Randomized Controlled Trial was designed to study the operation time,
      perioperative blood loss, conversion rate, duration of postoperative drainage, length of
      hospital stay, visual analogue score of postoperative pain, complications, and survival.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">December 25, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>operative time</measure>
    <time_frame>1 day</time_frame>
    <description>operative time in minutes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>perioperative blood loss</measure>
    <time_frame>1 day</time_frame>
    <description>perioperative blood loss in milliliter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>conversion rate</measure>
    <time_frame>1 day</time_frame>
    <description>conversion rate in proportion</description>
  </primary_outcome>
  <primary_outcome>
    <measure>duration of postoperative drainage</measure>
    <time_frame>within 5-7 days</time_frame>
    <description>duration of postoperative drainage in days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>length of hospital stay</measure>
    <time_frame>within 5-7 days</time_frame>
    <description>length of hospital stay in days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>visual analogue score of postoperative pain</measure>
    <time_frame>within 5-7 days</time_frame>
    <description>score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>complications</measure>
    <time_frame>up to 3 months</time_frame>
    <description>complications in rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>overall survival</measure>
    <time_frame>up to 5 years</time_frame>
    <description>overall survival in rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>progression- free survival</measure>
    <time_frame>up to 5 years</time_frame>
    <description>progression- free survival in rate</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Single-port Video-assisted Thoracoscopic Surgery</condition>
  <arm_group>
    <arm_group_label>single port group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Uniport video-assisted thoracoscopic surgery for NSCLC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>two ports group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>video-assisted thoracoscopic surgery for NSCLC using two ports</description>
  </arm_group>
  <arm_group>
    <arm_group_label>three ports group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>video-assisted thoracoscopic surgery for NSCLC using three ports</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>uniport video-assisted thoracoscopic surgery</intervention_name>
    <description>video-assisted thoracoscopic surgery for NSCLC using single port or two ports or three ports</description>
    <arm_group_label>single port group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>two ports video-assisted thoracoscopic surgery</intervention_name>
    <description>video-assisted thoracoscopic surgery for NSCLC using two ports</description>
    <arm_group_label>two ports group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>three ports video-assisted thoracoscopic surgery</intervention_name>
    <description>video-assisted thoracoscopic surgery for NSCLC using three ports</description>
    <arm_group_label>three ports group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        patients with cT1-3N0-1M0 NSCLC; good cardiopulmonary function; prepared to undergo radical
        resection;

        Exclusion Criteria:

        patients with N3 or M1 NSCLC; poor cardiopulmonary function; not be prepared to undergo
        radical resection;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiaogang Zhao, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>The Second Hospital of Shandong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yunpeng Zhao, Doctor</last_name>
    <phone>+8618766188692</phone>
    <email>zyp_baggio@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Second Hospital of Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250033</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yunpeng Zhao, doctor</last_name>
      <phone>+8618766188692</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>December 21, 2019</study_first_submitted>
  <study_first_submitted_qc>December 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 27, 2019</study_first_posted>
  <last_update_submitted>December 25, 2019</last_update_submitted>
  <last_update_submitted_qc>December 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Non Small Cell Lung Cancer</keyword>
  <keyword>Perioperative Efficacy</keyword>
  <keyword>multi-port</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

